SPHK1 and neoplasm: EVs are known to affect tumor progression by promoting metastasis, immune modulation, angiogenesis, and tissue regeneration.[8] However, how EVs containing SPHK1 and therefore S1P elevation modulate the tumor microenvironment is unknown.